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Abstract
Background: Clinical characteristics and complications of Duchenne muscular dystrophy caused
by skeletal and cardiac muscle degeneration are well known. Gastro-intestinal involvement has also
been recognised in these patients. However an acute perforated gastro-duodenal peptic ulcer has
not been documented up to now.
Case presentation: A 26-year-old male with Duchenne muscular dystrophy with a clinical and
radiographic diagnosis of acute perforated gastro-duodenal peptic ulcer is treated non-operatively
with naso-gastric suction and intravenous medication. Gastrointestinal involvement in Duchenne
muscular dystrophy and therapeutic considerations in a high risk patient are discussed.
Conclusion: Non-surgical treatment for perforated gastro-duodenal peptic ulcer should be
considered in high risk patients, as is the case in patients with Duchenne muscular dystrophy.
Patients must be carefully observed and operated on if non-operative treatment is unsuccessful.
Background
Duchenne muscular dystrophy (DMD) is a fatal X-linked
recessive disease. It is the most common congenital neu-
romuscular disorder of childhood [1]. It's clinical course
and characteristics caused by skeletal and cardiac muscle
degeneration are well known and documented [2]. Pro-
gressive muscle weakness inevitably results in the com-
plete inability to walk around the age of 11 [3]. By the age
of 18 patients are predisposed to serious pulmonary infec-
tions [4]. It leads to death before the age of 30. Gastro-
intestinal involvement is less well known. Dystrophic
changes in smooth muscle of the gastro-intestinal tract
have been implicated in causing gastro-intestinal dysfunc-
tion [5]. We want to present and discuss a patient with
Duchenne muscular dystrophy with a clinical and radio-
graphic diagnosis of acute perforated peptic ulcer. Treat-
ment options for an acute perforated peptic ulcer should
be well considered in a patient at pulmonary and cardiac
risk caused by DMD.
Case presentation
A 26-year-old male has DMD and is non-ambulatory. He
was presented on our emergency department because of
severe sudden onset abdominal pain. Upon presentation
there was sharp constant pain located in the epigastrium,
with nausea and vomiting. Complaints had been present
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gastrointestinal bleeding. On physical examination there
was direct tenderness in his abdomen with rebound ten-
derness and guarding. Bowel sounds were absent. His
body temperature was 38, 3°C, there was a tachycardia at
a rate of 150/min and blood pressure was 115/60 mmHg.
A sitting chest radiograph showed free air in the perito-
neum (figure 1).
Previous medical history was without respiratory aid and
no signs of nightly hypoxia, but with recurring episodes of
pneumonia. His functional vital capacity was 30% of the
predicted value. Two years ago he had two episodes of
acute gastric bleeding from peptic ulcer vessels; both diag-
nosed endoscopicaly and subsequently treated with endo-
scopic epinephrine injections with bipolar coaptation.
Thereafter Helicobacter Pylori (HP) eradication therapy
(omeprazole, metronidazole and clarithromycin for 7
days) was given, followed by a continuous use of omepra-
zol and sucralfate. Furthermore he was known to have a
chronically dilated stomach, with recurring episodes of
poor gastric passage and vomiting.
Based on his previous medical history and signs and
symptoms on current presentation a clinical diagnosis of
perforated peptic ulcer was established. The associated
perioperative risks of pulmonary dysfunction and cardiac
failure in this patient were high. Therefore non-operative
treatment for perforated peptic ulcer was started. The
patient was treated with continuous naso-gastric suction
(20 cm H2O) and intravenous omeprazol continuously
and regular doses of intravenous broad-spectrum antibi-
otics aimed at gram positive, gram negative and anaero-
bic-bacteria (Cefuroxim and Metronidazole) were
administered. The patient's symptoms rapidly improved
thereafter. After a five-day period the naso-gastric suction
tube was removed. The pain and nausea had subsided;
there was less direct tenderness in the abdomen and no
rebound tenderness or guarding. Bowel sounds were
present. Body temperature was normal. Oral intake of flu-
ids and solids was started. Twelve days after admission the
patient was dismissed from hospital in good clinical
condition.
Discussion
DMD is caused by a deletion in the dystrophin gene
located on the short arm of the X-chromosome [6]. The
resulting lack of dystrophin causes degeneration of stri-
ated muscle [7]. Respiratory dysfunction caused by dys-
trophic changes in respiratory muscle causing pulmonary
infection is the most common complication in DMD
[8,9]. Dystrophin is also present in smooth muscle. The
involvement of smooth muscle in addition to the progres-
sive dystrophic changes in striated muscle may cause clin-
ical dysfunction of the gastro-intestinal tract [10-12]. Both
gastric dilatation and intestinal pseudo-obstruction have
been described as gastro-intestinal complications in DMD
[13,14]. To provide evidence that smooth muscle is func-
tionally impaired in patients with DMD, Barohn et al.
compared gastric-emptying time between DMD patients
and healthy control subjects. They showed a significant
difference in gastric emptying time in patients with DMD.
Furthermore, on examination at autopsy degeneration
and loss of smooth gastro-intestinal muscle similar to
changes in skeletal and cardiac muscle were found in
DMD patients [15,16]. To our knowledge however there
are no reports on gastro-duodenal (perforated) peptic
ulcer as a complication in DMD.
The common treatment for patients with perforated pep-
tic ulcer is surgical repair [17]. In most cases an omental
patch repair is performed, followed by treatment with H2
receptor antagonists and if indicated HP eradication ther-
apy [18-20]. Non-operative treatment for perforated pep-
tic ulcer can be successful, as first reported by Taylor in
1957. He compared operative and non-operative treat-
ment for perforated peptic ulcer and reported similar mor-
tality rates in both groups (5%) [21]. Crofts et al.
compared the outcome of non-operative treatment with
that of emergency surgery in a randomised trial and
reported an overall mortality rate of 5% in each group and
no significant difference in morbidity [22]. Crofts et al.
conclude that an initial period of non-operative treatment
is safely allowed except in patients over 70 years old [23].
Kaene et al. reported favourable survival rates (2.4% mor-
tality) in a series of 42 patients treated non-operatively
compared with reported surgical mortality [24]. The
importance of careful clinical observation by an experi-
enced surgeon is emphasised in reported literature,
because non-operative treatment should be promptly
abandoned if unsuccessful [21,25,26].
In spite of those reports non-operative treatment has
never really been accepted as standard treatment [17,27].
However in selected cases non-operative treatment for
perforated peptic ulcer may be considered. Boey et al.
identified major medical illness, preoperative shock and
longstanding perforation, as perioperative risk factors
[28]. Based on these risk factors they correctly predicted
the outcome in 93.8% of patients in a series of 259
patients treated operatively for perforated peptic ulcer.
Mortality rate increased with the presence of one, two or
all three risk factors. Boey et al. conclude that non-opera-
tive treatment should be re-evaluated for patients with all
three risk factors because of their uniformly dismal out-
come after surgery [29]. Patients with DMD are at high
risk for perioperative respiratory dysfunction or heart fail-
ure [30-32]. Therefore in this case a non-operative
approach was well considered and proved to be
successful.Page 3 of 5
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This case demonstrates a gastro-duodenal peptic ulcer as a
possible complication in DMD. Furthermore it illustrates
that in pulmonary and cardiac high risk patients non-
operative treatment for perforated peptic ulcer can be suc-
cessful. If treated non-operatively patients should be care-





DMD: Duchenne muscular dystrophy
HP: Helicobacter Pylori
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